{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:09:32Z","timestamp":1780423772002,"version":"3.54.1"},"reference-count":37,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,1,3]]},"abstract":"<jats:p>Background: The uncompetitive NMDA antagonist, memantine (MEM), enhances prepulse inhibition of startle (PPI) across species. MEM is used to treat Alzheimer\u2019s disease (AD); conceivably, its acute impact on PPI might be used to predict a patient\u2019s sensitivity to MEM\u2019s therapeutic effects. Objective: To begin to test this possibility, we studied MEM effects on PPI and related measures in AD patients. Methods: 18 carefully screened individuals with AD (mean age\u200a=\u200a72.8 y; M:F=9\u200a:\u200a9) completed double-blind order-balanced testing with MEM (placebo versus 20\u200amg), assessing acoustic startle magnitude, habituation, PPI, and latency. Results: Fifteen out of 18 participants exhibited reliable startle responses. MEM did not significantly impact startle magnitude or habituation. Compared to placebo responses, PPI was significantly increased after MEM (p\u200a&lt;\u200a0.04; d\u200a=\u200a0.40); this comparison reached a large effect size for the 60\u200ams interval (d\u200a=\u200a0.62), where maximal MEM effects on PPI were previously detected. Prepulses reduced peak startle latency (\u201clatency facilitation\u201d) and this effect was amplified after MEM (p\u200a=\u200a0.03; d\u200a=\u200a0.41; for 60\u200ams intervals, d\u200a=\u200a0.69). No effects of MEM were detected on cognition, nor were MEM effects on startle associated with cognitive or clinical measures. Conclusion: MEM enhances prepulse effects on startle magnitude and latency in AD; these changes in PPI and latency facilitation with MEM suggest that these measures can be used to detect an AD patient\u2019s neural sensitivity to acute MEM challenge. Studies in progress will determine whether such a \u201cbiomarker\u201d measured at the outset on treatment can predict sensitivity to MEM\u2019s therapeutic effects.<\/jats:p>","DOI":"10.3233\/jad-220769","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T10:46:56Z","timestamp":1668768416000},"page":"355-362","source":"Crossref","is-referenced-by-count":4,"title":["Preliminary Evidence that Memantine Enhances Prepulse Effects on Startle Magnitude and Latency in Patients with Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"91","author":[{"given":"Neal R.","family":"Swerdlow","sequence":"first","affiliation":[{"name":"Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA, USA"},{"name":"VISN-22 Mental Illness, Research, Education and Clinical Center (MIRECC), VA San Diego Healthcare System, San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yash B.","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA, USA"},{"name":"VISN-22 Mental Illness, Research, Education and Clinical Center (MIRECC), VA San Diego Healthcare System, San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Sprock","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA, USA"},{"name":"VISN-22 Mental Illness, Research, Education and Clinical Center (MIRECC), VA San Diego Healthcare System, San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Talledo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan L.","family":"Molina","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA, USA"},{"name":"VISN-22 Mental Illness, Research, Education and Clinical Center (MIRECC), VA San Diego Healthcare System, San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Delano-Wood","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Iwanaga","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana E.","family":"Kotz","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Huege","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel C.","family":"L\u00e9ger","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, School of Medicine, University of California, San Diego, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Light","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA, USA"},{"name":"VISN-22 Mental Illness, Research, Education and Clinical Center (MIRECC), VA San Diego Healthcare System, San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-220769_ref1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.brainresbull.2007.01.007","article-title":"Effects of NMDA receptor antagonist memantine on mismatch negativity","volume":"72","author":"Korostenskaja","year":"2007","journal-title":"Brain Res Bull"},{"key":"10.3233\/JAD-220769_ref2","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/npp.2009.7","article-title":"The effects of memantine on prepulse inhibition","volume":"34","author":"Swerdlow","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-220769_ref3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.neuroscience.2010.03.014","article-title":"Dose-related effects of memantine on a mismatch negativity-like response in anesthetized rats","volume":"167","author":"Tikhonravov","year":"2010","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-220769_ref4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/npp.2015.162","article-title":"Memantine effects on sensorimotor gating and mismatch negativity in patients with chronic psychosis","volume":"41","author":"Swerdlow","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-220769_ref5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuroscience.2018.07.027","article-title":"Small arms fire-like noise: Effects on hearing loss, gap detection and the influence of preventive treatment","volume":"407","author":"Altschuler","year":"2019","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-220769_ref6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5607\/en.2019.28.4.495","article-title":"Memantine attenuates salicylate-induced tinnitus possibly by reducing NR2B expression in auditory cortex of rat","volume":"28","author":"Jang","year":"2019","journal-title":"Exp Neurobiol"},{"key":"10.3233\/JAD-220769_ref7","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/s41386-020-00865-8","article-title":"Memantine effects on auditory discrimination and training in schizophrenia patients","volume":"45","author":"Swerdlow","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-220769_ref8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40120-017-0067-7","article-title":"A real-world analysis of treatment patterns for cholinesterase inhibitors and memantine among newly-diagnosed Alzheimer\u2019s disease patients","volume":"6","author":"Bent-Ennakhil","year":"2017","journal-title":"Neurol Ther"},{"key":"10.3233\/JAD-220769_ref9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3233\/JAD-170424","article-title":"Memantine for Alzheimer\u2019s disease: An updated systematic review and meta-analysis","volume":"60","author":"Kishi","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220769_ref10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jalz.2006.10.004","article-title":"Meta-analysis of six-month memantine trials in Alzheimer\u2019s disease","volume":"3","author":"Doody","year":"2007","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220769_ref11","first-page":"CD003154","article-title":"Memantine for dementia","volume":"3","author":"McShane","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3233\/JAD-220769_ref12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/01.JGP.0000224350.82719.83","article-title":"Memantine treatment in mild to moderate Alzheimer disease: A 24-week randomized, controlled trial","volume":"14","author":"Peskind","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-220769_ref13","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3233\/JAD-215029","article-title":"Using biomarkers to predict memantine effects in Alzheimer\u2019s disease: A proposal and proof-of-concept demonstration","volume":"84","author":"Swerdlow","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220769_ref14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-220769_ref15","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer\u2019s disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-220769_ref16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1176\/jnp.12.2.233","article-title":"Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory","volume":"12","author":"Kaufer","year":"2000","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.3233\/JAD-220769_ref17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: A preliminary report","volume":"17","author":"Yesavage","year":"1983","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-220769_ref18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging and the Alzheimer\u2019s Association workgroup","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220769_ref19","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1038\/npp.2017.81","article-title":"Single-dose memantine improves cortical oscillatory response dynamics in patients with schizophrenia","volume":"42","author":"Light","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-220769_ref20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.acn.2008.06.004","article-title":"Utility of the RBANS in detecting cognitive impairment associated with Alzheimer\u2019s disease: Sensitivity, specificity, and positive and negative predictive powers","volume":"23","author":"Duff","year":"2008","journal-title":"Arch Clin Neuropsychol"},{"key":"10.3233\/JAD-220769_ref21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0006-3223(93)90079-S","article-title":"Men are more inhibited than women by weak prepulses","volume":"34","author":"Swerdlow","year":"1993","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-220769_ref22","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1176\/appi.ajp.2020.20081212","article-title":"Anticholinergic medication burden-associated cognitive impairment in schizophrenia","volume":"178","author":"Joshi","year":"2021","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-220769_ref23","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/npp.2017.285","article-title":"Effects of amphetamine on sensorimotor gating and neurocognition in antipsychotic-medicated schizophrenia patients","volume":"43","author":"Swerdlow","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-220769_ref24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1176\/ajp.156.4.596","article-title":"Symptom correlates of prepulse inhibition deficits in male schizophrenic patients","volume":"156","author":"Braff","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-220769_ref25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/jnnp.58.2.192","article-title":"Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington\u2019s disease","volume":"58","author":"Swerdlow","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-220769_ref26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.pscychresns.2011.07.007","article-title":"White matter hyperintensities and prepulse inhibition in a mixed elderly population","volume":"194","author":"Salem","year":"2011","journal-title":"Psychiatry Res"},{"key":"10.3233\/JAD-220769_ref27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0301-0511(02)00126-6","article-title":"The relationship of age to prepulse inhibition and habituation of the acoustic startle response","volume":"62","author":"Ellwanger","year":"2003","journal-title":"Biol Psychol"},{"key":"10.3233\/JAD-220769_ref28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1121\/1.1911919","article-title":"Role of weak signals in acoustic startle","volume":"47","author":"Hoffman","year":"1970","journal-title":"J Acoust Soc Am"},{"key":"10.3233\/JAD-220769_ref29","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/0031-9384(73)90185-6","article-title":"Latency and amplitude changes in the acoustic startle reflex of the rat produced by variation in auditory prestimulation","volume":"10","author":"Ison","year":"1973","journal-title":"Physiol Behav"},{"key":"10.3233\/JAD-220769_ref30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jalz.2009.05.604","article-title":"Treatment effects of Memantine on language in moderate to severe Alzheimer\u2019s disease patients","volume":"5","author":"Ferris","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220769_ref31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JAD-2011-110947","article-title":"Memantine and functional communication in Alzheimer\u2019s disease: Results of a 12-week, international, randomized clinical trial","volume":"28","author":"Graham","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220769_ref32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JAD-2011-110947","article-title":"Memantine and functional communication in Alzheimer\u2019s disease: Results of a 12-week, international, randomized clinical trial","volume":"28","author":"Saxton","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220769_ref33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3233\/JAD-2011-101929","article-title":"Sustained effects of once-daily memantine treatment on cognition and functional communication skills in patients with moderate to severe Alzheimer\u2019s disease: Results of a 16-week open-label trial","volume":"25","author":"Schulz","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220769_ref34","first-page":"357","article-title":"Effects of memantine treatment on language abilities and functional communication in patients with moderate to severe Alzheimer\u2019s disease: A review of data","volume":"17","author":"Tocco","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-220769_ref35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0028-3908(03)00073-X","article-title":"Low dose ketamine increases prepulse inhibition in healthy men","volume":"44","author":"Abel","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-220769_ref36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0893-133X(00)00240-2","article-title":"Clinical and sensorimotor gating effects of ketamine in normals","volume":"25","author":"Duncan","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-220769_ref37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archneurol.2010.343","article-title":"Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer\u2019s Disease Neuroimaging Initiative","volume":"68","author":"Schneider","year":"2011","journal-title":"Arch Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-220769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:02Z","timestamp":1777370882000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-220769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":37,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-220769","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]}}}